Ocular Therapeutix, Inc. (OCUL)

9.16 -0.34 (-3.58%) USD  |  NASDAQ  |  May 15, 16:00
9.165 0.00 (0.00%) After-Hours: 20:00
More

Ocular Therapeutix EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for OCUL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
EyePoint, Inc. Upgrade
Merck & Co., Inc. Upgrade
Zevra Therapeutics, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade